Medical/Pharmaceuticals
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic™ Clinical Trial
BELTSVILLE, Md., May 3, 2023 /PRNewswire/ -- Reprocell USA, a CRO, has been awarded a contract to provide support for Lantern Pharma's Phase 2 clinical trial entitled "A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers with Advanced Lung Adenocarcinoma (HARMONIC)". The Harmonic™ s...
2023-05-03 21:00
2026
Healthcare Veteran, Zach Henderson to lead Global Kinetics as CEO
CHARLOTTE, N.C. and MELBOURNE, Australia, May 3, 2023 /PRNewswire/ -- Global Kinetics, the global leader in digital health solutions for neurological conditions, today announced the appointment of Zach Henderson as its new Chief Executive Officer. Zach will also join the Board of Directors. Za...
2023-05-03 21:00
2105
LenioBio GmbH Announces New CEO
DUSSELDORF, Germany, May 3, 2023 /PRNewswire/ -- LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr.Remberto Martis, will be stepping down as CEO and has proudly named his successor as André Goerke, startingJune 1st, 2023. Andr...
2023-05-03 20:00
2357
Chula Researchers Develop Rapid MTB Strip Test for Tuberculosis
Lecturers of the Faculty of Allied Health Sciences, Chulalongkorn University have developed the MTB Strip Test Kit for Tuberculosis (TB) diagnosis that's accurate and easy to use, guaranteed by the 2023 Invention Award from the National Research Council of Thailand (NRCT) -- Another hope to reduce...
2023-05-03 11:34
3013
Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea
* MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem * Proposed bioprocessing facility to be based in Daejeon City * Further collaboration aims to support emerging biotech companies and academic research DAEJEON CITY, South Korea, May 3, 2023 /PRNe...
2023-05-03 10:00
3103
Sourcing Ideal Medical Device Materials: Experience ICP DAS - BMP medical-grade TPUs at 2023 CMEF Shanghai, China
HSINCHU, May 3, 2023 /PRNewswire/ -- Material "safety" and "quality" are paramount to medical device manufacturers. Therefore, ICP DAS - BMP (Biomedical Polymers), aTaiwan medical-grade TPU (thermoplastic polyurethane) supplier, will partake in CMEF (ICMD) to further make known our highly-stable ...
2023-05-03 09:46
2756
Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients
SUZHOU, China, May 3, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces that the enrollment of ...
2023-05-03 08:00
3561
ZEISS Presents New Surgical Workflow Innovations at ASCRS
New products help doctors diagnose and treat patients within the cataract and corneal refractive workflows. JENA, Germany and DUBLIN, Calif., May 3, 2023 /PRNewswire/ -- ZEISS Medical Technology will showcase new surgical workflow innovations at the American Society of Cataract and Refractive Su...
2023-05-03 02:09
2394
Turacoz Forges Ahead with Veeva Content Certification & Training for Professionals
UTRECHT, Netherlands and NEW DELHI, May 3, 2023 /PRNewswire/ -- Turacoz Healthcare Solutions has been making strides in the field of medical communications using cutting-edge technologies. The demand for high-quality scientific and medical writing is increasing, and Turacoz is leading the way in ...
2023-05-03 01:55
2405
Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis
The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment with sparsentan resulted in a reduction of proteinuria that was sustained through 108 weeks of treatment S...
2023-05-03 00:22
3146
iHerb Names Miriee Chang as Chief Operating Officer
Newly established role will further streamline operations and enhance operational effectiveness IRVINE, Calif., May 3, 2023 /PRNewswire/ -- iHerb Holdings, LLC, announced that Miriee Chang has been named its Chief Operating Officer (COO). Mrs. Chang brings significant leadership experience to th...
2023-05-03 00:14
2572
Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis
* First patient dosed with CK0803 Treg cells for treatment of amyotrophic lateral sclerosis (ALS). * Ongoing Phase 1/1b study evaluating safety and efficacy of CK0803. HOUSTON, May 3, 2023 /PRNewswire/ -- Cellenkos® Inc., a clinical stage biotechnology company focused on developing allogeneic...
2023-05-03 00:07
1897
Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne
HANGZHOU and SHAOXING, China, May 2, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that ASC40 (Denifanstat), a first-in-class, once-daily oral fatty acid synthase (FASN) inhibitor, achieved primary and key secondary endpoints in Phase II clinical trial for acn...
2023-05-02 17:30
2812
Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology
* Combined broad and differentiated portfolio with trusted technologies and commercial and service organizations * Customers will have simpler and greater access to industry-leading expertise, tools, and services AMERSHAM, United Kingdom, May 2, 2023 /PRNewswire/ -- Cytiva and the life scienc...
2023-05-02 12:01
3140
First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide
MELBOURNE, Australia, May 2, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first patients have been imaged inCanada with its commercially available prostate cancer imaging agent, Illuccix® [kit for the preparation of gallium (68Ga) PSMA-11 for i...
2023-05-02 05:00
2112
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease
TAMPA, Fla., May 1, 2023 /PRNewswire/ -- The US FDA has granted an
Investigational Device Exemption (IDE) approval for Concept Medical Inc's novel
MagicTouch
2023-05-01 18:30
2552
Zimmer Biomet Announces Acquisition of OSSIS
SINGAPORE, May 1, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it has reached a definitive agreement to acquire OSSIS, a privately-held medical device company that specializes in personalized 3D printed implants, as wel...
2023-05-01 12:00
4689
GILEAD SCIENCES ANNOUNCES LAUNCH OF ASIA PACIFIC RAINBOW GRANT 2023
–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organizations across the Asia Pacific Region to Date – – Grant Program in 2023 Invites HIV-Focused Community-Based Organizations to Apply for Funding for Innova...
2023-05-01 11:00
2979
ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller
MELBOURNE, Australia, May 1, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89 Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalT...
2023-05-01 08:58
2488
European Wellness Collaborates with Heidelberg University in Journal Publications of "Synergistic Anti-Ageing Through Senescent Cells Specific Reprogramming"
HEIDELBERG, Germany, April 28, 2023 /PRNewswire/ -- European Wellness Academy (EWA), an educational arm of European Wellness Biomedical Group (EW Group), has collaborated with Heidelberg University on journal publication. The research project, titled "Synergistic Anti-Ageing Through Senescent Cel...
2023-04-28 11:58
2520
Week's Top Stories
Most Reposted
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 321 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 312 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 299 media titles]
2024-05-08 16:44
Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic
[Picked up by 289 media titles]
2024-05-09 11:00
i2Cool Attracts Close to HKD100 Million in Series A Financing to Propel the Development of Green and Energy-Efficient Radiant Cooling Solutions
[Picked up by 283 media titles]
2024-05-09 10:50
Most Read
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
2024-05-08 14:37
12709
IN2MF in Kuala Lumpur Presented by Bank Indonesia
2024-05-08 16:44
12222
